Skip to main content
. 2018 Feb 12;45(2):146–155. doi: 10.1097/WON.0000000000000416

TABLE 4. Incidence and Severity of PSCsa.

Parameter SoC CIB
Annual probability of PSC 55% (41/74) 41% (32/79)
Proportion of patients who experience a second PSC, among patients who already experienced a PSC, without addition of accessory 15% 10%
Reduction in the incidence of a second PSC with the addition of an accessoryb 50% 50%
Probability first PSC is mild 69% (28/41) 72% (23/32)
Probability first PSC is moderate 29% (12/41) 25% (8/32)
Probability first PSC is severe 2% (1/41) 3% (1/32)
Probability second PSC is mild, given first PSC is mild 0% (0/1) 33%c
Probability second PSC is moderate, given first PSC is mild 100% (1/1) 33%c
Probability second PSC is severe, given first PSC is mild 0% (0/1) 34%c
Probability second PSC is mild, given first PSC is moderate 0% (0/1) 33%c
Probability second PSC is moderate, given first PSC is moderate 100% (1/1) 33%c
Probability second PSC is severe, given first PSC is moderate 0% (0/1) 34%c
Probability second PSC is mild, given first PSC is severe 33%c 33%c
Probability second PSC is moderate, given first PSC is severe 33%c 33%c
Probability second PSC is severe, given first PSC is severe 34%c 34%c

Abbreviations: CIB, ceramide-infused skin barrier; PSC, peristomal skin complication; SoC, standard of care.

aNumerators and denominators are in parentheses.

bADVOCATE Study did not provide input on this parameter. Both ceramide-infused skin barrier and SoC values were assumed to be 50% to be conservative.

cNo values were observed in ADVOCATE; these values are assumptions.